Genetic determinants and epidemiology of cystic fibrosis-related diabetes: Results from a british cohort of children and adults

Diabetes Care

Volumn 31, Issue 9, 2008, Pages 1789-1794

  Adler, Amanda I ^a   Shine, Brian S F ^b   Chamnan, Parinya ^c   Haworth, Charles S ^d   Bilton, Diana ^e  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

^b JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^c MRC EPIDEMIOLOGY UNIT   (United Kingdom)

^d PAPWORTH HOSPITAL   (United Kingdom)

^e ROYAL BROMPTON HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; CORTICOSTEROID; TRANSMEMBRANE CONDUCTANCE REGULATOR;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTICLE; CHILD; COHORT ANALYSIS; CORTICOSTEROID THERAPY; CYSTIC FIBROSIS; CYSTIC FIBROSIS RELATED DIABETES; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; GENE MUTATION; GENETIC ANALYSIS; HUMAN; INCIDENCE; INDEPENDENT VARIABLE; LIVER DYSFUNCTION; LONGITUDINAL STUDY; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; ORAL GLUCOSE TOLERANCE TEST; PANCREAS INSUFFICIENCY; POPULATION RESEARCH; REGISTER; RISK ASSESSMENT; RISK FACTOR; SCHOOL CHILD; SEX DIFFERENCE; UNITED KINGDOM; BODY MASS; GENETICS; INFANT; MIDDLE AGED; ONSET AGE; PRESCHOOL CHILD;

ADOLESCENT; ADULT; AGE OF ONSET; BODY MASS INDEX; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; CYSTIC FIBROSIS; DIABETES COMPLICATIONS; FEMALE; GREAT BRITAIN; HUMANS; INCIDENCE; INFANT; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; RISK FACTORS;

EID: 56149086854     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc08-0466     Document Type: Article

References (26)

1. Moran A, Doherty L, Wang X, Thomas W: Abnormal glucose metabolism in cystic fibrosis. J Pediatr 133:10-17, 1998
2. Lanng S, Hansen A, Thorsteinsson B, Nerup J, Koch C: Glucose tolerance in patients with cystic fibrosis: five year prospective study. BMJ 311:655-659, 1995
3. Adler AI, Gunn E, Haworth C, Bilton D: Characteristics of adults with and without cystic fibrosis-related diabetes. Diabet Med 24:1143-1148, 2007
4. Marshall B, Butler S, Stoddard M, Moran A, Liou T, Morgan W: Epidemiology of cystic fibrosis-related diabetes. J Pediatr 146:681-687, 2005
5. Koch C, Rainisio M, Madessani U, Harms HK, Hodson ME, Mastella G, McKenzie SG, Navarro J, Strandvik B: Presence of cystic fibrosis-related diabetes mellitus is tightly linked to poor lung function in patients with cystic fibrosis: data from the European Epidemiologic Registry of Cystic Fibrosis. Pediatr Pulmonol 32:343-350, 2001
6. Sims EJ, Green M, Mehta A: Decreased lung function in female but not male subjects with established cystic fibrosis- related diabetes. Diabetes Care 28:1581-1587, 2005
7. Koch C, Cuppens H, Rainisio M, Madessani U, Harms H, Hodson M, Mastella G, Navarro J, Strandvik B, McKenzie S: European Epidemiologic Registry of Cystic Fibrosis (ERCF): comparison of major disease manifestations between patients with different classes of mutations. Pediatr Pulmonol 31:1-12, 2001
8. Cucinotta D, De Luca F, Scoglio R, Lombardo F, Sferlazzas C, Di Benedetto A, Magazzu G, Raimondo G, Arrigo T: Factors affecting diabetes mellitus onset in cystic fibrosis: evidence from a 10-year follow-up study. Acta Paediatr 88:389-393, 1999
9. Rosenfeld M, Davis R, FitzSimmons S, Pepe M, Ramsey B: Gender gap in cystic fibrosis mortality. Am J Epidemiol 145:794-803, 1997
10. Pan H, Cole T: User's Guide to lms Growth [article online], 2007. London, Medical Research Council UK. Available from http://www. healthforallchildren.co.uk/pro.epl?DO=USERPAGE&PAGE=Imsdownload. Accessed 30 April 2008
11. Hankinson J, Odencrantz J, Fedan K: Spirometric reference values from a sample of the U.S. population. Am J Respir Crit Care Med 159:179-187, 1999
12. Rowntree RK, Harris A: The phenotypic consequences of CFTR mutations. Ann Intern Med 67:471-485, 2003
13. McKone EF, Emerson SS, Edwards KL, Aitken ML: Effect of genotype on phenotype and mortality in cystic fibrosis: a retrospective cohort study. Lancet 361: 1671-1676, 2003
14. Nousia-Arvanitakis S, Galli-Tsinopoulou A, Karamouzis I: Insulin improves clinical status of patients with cystic-fibrosis- related diabetes mellitus. Acta Paediatr 90:515-519, 2001
15. Ahmed N, Corey M, Forstner G, Zielenski J, Tsui LC, Ellis L, Tullis E, Durie P: Molecular consequences of cystic fibrosis transmembrane regulator (CFTR) gene mutations in the exocrine pancreas. Gut 52:1159-1164, 2003
16. Rosenecker J, Eichler I, Kuhn L, Harms H, von der Hardt H: Genetic determination of diabetes mellitus in patients with cystic fibrosis: a multicenter study screening fecal elastase 1 concentrations in 1, 021 diabetic patients. J Pediatr 127:441-443, 1995
17. Hamdi I, Payne SJ, Barton DE, McMahon R, Green M, Shneerson JM, Hales CN: Genotype analysis in cystic fibrosis in relation to the occurrence of diabetes mellitus. Clin Genet 43:186-189, 1993
18. Dominguez-Garcia A, Quinteiro-Gonzalez S, Pena-Quintana L, Ramos-Macias L, Quintana-Martel M, Saavedra-Santana P: Carbohydrate metabolism changes in cystic fibrosis. J Pediatr Endocrinol Metab 20:621-632, 2007
19. Preumont V, Hermans MP, Lebecque P, Buysschaert M: Glucose homeostasis and genotype-phenotype interplay in cystic fibrosis patients with CFTR gene AF508 mutation. Diabetes Care 30:1187-1192, 2007
20. Boom A, Lybaert P, Pollet JF, Jacobs P, Jijakli H, Golstein PE, Sener A, Malaisse WJ, Beauwens R: Expression and localization of cystic fibrosis transmembrane conductance regulator in the rat endocrine pancreas. Endocrine 32:197-205, 2007
21. Stalvey MS, Muller C, Schatz DA, Wasserfall CH, Campbell-Thompson ML, Theriaque DW, Flotte TR, Atkinson MA: Cystic fibrosis transmembrane conductance regulator deficiency exacerbates islet cell dysfunction after β-cell injury. Diabetes 55:1939-1945, 2006
22. Mulberg AE, Weyler RF, Altschuler SM, Hyde TM: Cystic fibrosis transmembrane conductance regulator expression in human hypothalamus. Neuroreport 9:141-144, 1998
23. Littlewood JM, Wolfe SP, Conway SP: Diagnosis and treatment of intestinal malabsorption in cystic fibrosis. Pediatr Pulmonol 41:35-49, 2006
24. Rosenecker J, Hofler R, Steinkamp G, Eichler I, Smaczny C, Ballmann M, Posselt HG, Bargon J, von der Hardt H: Diabetes mellitus in patients with cystic fibrosis: the impact of diabetes mellitus on pulmonary function and clinical outcome. Eur J Med Res 6:345-350, 2001
25. Milla CE, Billings J, Moran A: Diabetes is associated with dramatically decreased survival in female but not male subjects with cystic fibrosis. Diabetes Care 28: 2141-2144, 2005
26. Hsia CC, Raskin P: The diabetic lung: relevance of alveolar microangiopathy for the use of inhaled insulin. Am J Med 118:205-211, 2005